C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,610 | 61,274 | 74,603 | 58,809 | 78,157 |
| Marketable Securities | 175,053 | 174,397 | 173,934 | 133,075 | 136,397 |
| Receivables | 1,334 | 2,883 | 2,401 | 6,542 | 2,158 |
| TOTAL | $262,902 | $245,371 | $258,110 | $206,864 | $224,729 |
| Non-Current Assets | |||||
| PPE Net | 4,149 | 4,492 | 4,744 | 5,134 | 5,540 |
| Investments And Advances | 46,786 | 32,600 | 48,563 | 7,875 | 8,419 |
| Other Non-Current Assets | 45,567 | 46,398 | 47,658 | 45,615 | 57,839 |
| TOTAL | $96,502 | $83,490 | $100,965 | $58,624 | $71,798 |
| Total Assets | $359,404 | $328,861 | $359,075 | $265,488 | $296,527 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,121 | 773 | 858 | 1,333 | 2,216 |
| Accrued Expenses | 13,785 | 9,830 | 13,314 | 11,270 | 13,554 |
| TOTAL | $48,247 | $27,249 | $33,032 | $35,945 | $44,456 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 26,661 | 10,124 | 12,493 | 17,126 | 22,620 |
| Other Non-Current Liabilities | 50,178 | 51,925 | 53,615 | 55,247 | 56,857 |
| TOTAL | $63,892 | $67,365 | $69,456 | $75,135 | $78,007 |
| Total Liabilities | $112,139 | $94,614 | $102,488 | $111,080 | $122,463 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,025 | 110,567 | 97,578 | 96,914 | 71,171 |
| Common Shares | 12 | 10 | 9 | 7 | 7 |
| Retained earnings | -787,457 | -763,822 | -738,693 | -718,207 | -686,041 |
| Other shareholders' equity | -444 | -322 | 50 | 87 | -30 |
| TOTAL | $247,265 | $234,247 | $256,587 | $154,408 | $174,064 |
| Total Liabilities And Equity | $359,404 | $328,861 | $359,075 | $265,488 | $296,527 |